CEFPIROME IN GYNECOLOGICAL INFECTIONS

We studied the clinical efficacy of cefpirome (CPR) in gynecological infections by treating patients with 0.5-1.0g/day intravenously and obtained the following results. 1. The response to CPR was good in all 13 patients with gynecological infections (endometritis 8, salpingitis 3, Bartholin's g...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 39; no. Supplement1; pp. 653 - 656
Main Authors IMAGAWA, NOBUYUKI, ISHIKAWA, TAKUJI, HAYASHI, SHIGEOKI, HAYASHI, MOICHIROH, KAWAKATSU, MASAHIDE, YAMATO, TATSUO
Format Journal Article
LanguageEnglish
Japanese
Published Japanese Society of Chemotherapy 1991
公益社団法人 日本化学療法学会
Subjects
Cefpirome
産婦人科領域感染症
臨床成績
Online AccessGet full text
ISSN0009-3165
1884-5894
DOI10.11250/chemotherapy1953.39.Supplement1_653

Cover

More Information
Summary:We studied the clinical efficacy of cefpirome (CPR) in gynecological infections by treating patients with 0.5-1.0g/day intravenously and obtained the following results. 1. The response to CPR was good in all 13 patients with gynecological infections (endometritis 8, salpingitis 3, Bartholin's gland abscess 2). 2. In a bacteriological study, 9 strains were isolated from 8 cases. All strains were eradicated. 3. There were no side effects or abnormal laboratory findings.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.39.Supplement1_653